Clinical Trial Update: Clinical and Radiographic Evaluation of Zinc Oxide Modified 3Mixtatin Versus Zical in Root Canal Treatment of Necrotic Primary Molars. [NA]

View source ↗

Summary

This clinical trial update evaluates zinc oxide modified 3Mixtatin against Zical for root canal treatment of necrotic primary molars; no results or status detai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulp Necrosis

Drugs mentioned

• Zical (Zical)
• Zinc Oxide Modified 3Mixtatin (3Mixtatin (zinc oxide modified))

Snippet

Sponsor: Ain Shams University | Conditions: Necrotic Pulp, Primary Teeth | NA | Status: UNKNOWN